Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
ATHENAHEALTH INC (ATHN)
|
Add to portfolio |
|
|
|
| Price: |
$134.86
| | Metrics |
| OS: |
40.6
|
M
| |
12
|
% ROE
|
| Market cap: |
$5.48
|
B
| |
18
|
% ROIC
|
|
Net cash:
|
$45.3
|
M
| |
$1.12
|
per share
|
|
EV:
|
$5.43
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$200
|
M
| |
27.1
|
x EV/EBITDA
|
|
EBIT
|
$162
|
M
| |
33.5
|
x EV/EBIT
|
| EPS |
$3.06
| |
44.1
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 1,220.3 | 1,082.9 | 924.7 | 752.6 | 595.0 | 422.3 | 324.1 | 245.5 |
| Revenue growth | 12.7% | 17.1% | 22.9% | 26.5% | 40.9% | 30.3% | 32.0% | 30.2% |
| Cost of goods sold | 578.5 | 533.5 | 462.2 | 368.7 | 238.7 | 166.9 | 122.8 | 96.6 |
| Gross profit | 641.8 | 549.4 | 462.5 | 383.9 | 356.3 | 255.4 | 201.3 | 149.0 |
| Gross margin | 52.6% | 50.7% | 50.0% | 51.0% | 59.9% | 60.5% | 62.1% | 60.7% |
| Sales and marketing | 252.2 | 256.6 | 237.3 | 196.8 | 149.5 | 104.3 | 79.8 | 52.7 |
| Research and development | 173.6 | 134.5 | 111.0 | 82.7 | 57.6 | 33.8 | 23.3 | 18.4 |
| General and administrative | 145.4 | 131.7 | 118.3 | 103.4 | 99.8 | 57.0 | 48.7 | 43.1 |
| EBITA | 89.9 | 47.4 | 19.9 | 29.6 | 23.8 | 38.0 | 34.9 | 25.4 |
| EBITA margin | 7.4% | 4.4% | 2.2% | 3.9% | 4.0% | 9.0% | 10.8% | 10.3% |
| Amortization of intangibles | 19.3 | 20.8 | 24.0 | 28.6 | 17.9 | 3.4 | 2.2 | 1.8 |
| EBIT | 70.6 | 26.6 | -4.1 | 1.0 | 5.9 | 34.6 | 32.7 | 23.6 |
| EBIT margin | 5.8% | 2.5% | -0.4% | 0.1% | 1.0% | 8.2% | 10.1% | 9.6% |
| Pre-tax income | 63.9 | 21.0 | 18.9 | -3.8 | 2.2 | 34.9 | 32.9 | 23.1 |
| Income taxes | 10.8 | 0.0 | 4.9 | -0.7 | -0.4 | 16.1 | 13.8 | 10.4 |
| Tax rate | 16.9% | 0.0% | 25.9% | 18.4% | | 46.3% | 42.1% | 45.0% |
| Net income | 53.1 | 21.0 | 14.0 | -3.1 | 2.6 | 18.7 | 19.0 | 12.7 |
| Net margin | 4.4% | 1.9% | 1.5% | -0.4% | 0.4% | 4.4% | 5.9% | 5.2% |
| |
| Diluted EPS | $1.30 | $0.52 | $0.35 | ($0.08) | $0.07 | $0.50 | $0.53 | $0.36 |
| Shares outstanding (diluted) | 40.7 | 40.1 | 39.6 | 37.9 | 38.3 | 37.1 | 36.1 | 35.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|